“Real Voices”
Akira Takano, Executive Chairman
GMO Financial Gate, Inc.
Aiming to Create a Cashless Society
—In an attempt to penetrate an oligopoly formed by two major players
Ever since I started my career, I have constantly devoted myself to sales jobs. Starting with Casio Computer, I have worked at various companies with a primary focus on sales. I joined the predecessor company in 2010 when it joined the GMO Internet Group and I was appointed president. Mr. Issei Ainoura, the then president of GMO-PG, asked me to use my sales skills to help rebuild the company, which was in an earnings slump. Both President Ainoura and I once worked on the same team at IBM Japan.
As I developed my career, I came up with the idea of utilizing expertise in making things to provide services to society. This eventually encouraged me to join GMO-PG in 2014, where I learned management skills while working on service development with particular focus on the field of E-commerce. I then joined GMO-FG in 2017, which coincided with the time when cashless services were about to grow further with an attractive market environment potentially offering big business opportunities. Another factor that encouraged me to switch careers was the presence of attractive people at GMO-FG, including Chairman Takano, which convinced me that a strong team would be put in place.
—Helping hand for last-ditch effort
Mr. Shimizu was in charge of GMO-PG and was well aware of President Aiura's competence. Mr. Shimizu later said, "E-commerce has grown and prevailed just as President Aiura predicted. So GMO-FG has a good chance of being successful as it plans to do a similar business using face-to-face payment. Particularly reassuring is that you are in charge of the business as Ainoura gave his confidence to you." I truly felt indebted to Mr. Shimizu as he extended a helping hand to us at a critical moment.
—Confidence in your partner is the ultimate contribution
In contrast, some of the other venture capitals cut off contact with us after categorically denied our business plan. When I was at a different company before, I once had business with a venture capital related to a business company, which generously offered us funds but immediately tried to collect them by requesting us to buy their own products. I thought that any venture capital was more or less like that, but MUCAP was completely different. As far as we are concerned, relationship with MUCAP has been not just business, but person-to-person interaction. They gave us their confidence to the extent that we felt enthusiastic, determined not to leave our responsibility unfulfilled and to live up to more than their expectations. This encouraged us to achieve beyond our real strength. What I learned from Mr. Shimizu of MUCAP is that confidence in your partner is the ultimate contribution.
Furthermore, as Chairman Takano mentioned, it is impressive that he has been a good listener, always trying to understand everything from the market environment to our growth strategy. MUCAP is the only entity that carefully listened to us and understood how the trend of cashless payment would play out in the future, including its social background. When we consulted with MUCAP to seek advice, saying "We want to take this opportunity to implement these measures and this requires us to postpone the date of listing," they immediately responded: "Yes, it should be postponed. We will discuss the matter in our company to gain understanding." I am truly grateful to MUCAP for their constant and step-by-step support to help us become a listed company.
—Supporting the shift to cashless in all industries and business types
Company
GMO Financial Gate, Inc.
Primary business activities
Company History
| 1999 | September | Established C.O.C. Inc., predecessor of The Company |
|---|---|---|
| 2009 | November | All shares acquired by INES Corporation |
| 2010 | January | All shares acquired by GMO Payment Gateway Inc. Becomes an equity method affiliate of GMO Payment Gateway Inc. |
| 2015 | April | Company name changed to GMO Financial Gate, Inc. |
| 2016 | January | Starts sales of VEGA3000, a hybrid payment terminal, The Company's flagship product |
| September | Capital increase through third-party allotment to GMO Payment Gateway, Inc. and others. Becomes a consolidated subsidiary of GMO Payment Gateway, Inc. | |
| 2017 | October | Launches payment service using embedded terminals. Starts sales activities targeting beverage manufacturers, vending machine manufacturers, etc. |
| 2019 | August | Establishment of GMO Data, Inc., a joint venture with Sumitomo Mitsui Card Co., Ltd. |
| 2020 | July | Initial listing on the Tokyo Stock Exchange Mothers market |
-
Transforming the future of cancer treatment through drug development
Hiroshi Miyake, Ph.D.
CEO, Chordia Therapeutics Inc. -
Bringing a breath of fresh air to senior high school graduate recruitment
Mitsuhide Sasaki
President, JINJIB Co., Ltd. -
Solving the space debris problem and achieving sustainability in space and on earth
Mitsunobu Okada, Founder and CEO Nobuhiro Matsuyama, Chief Financial Officer
Astroscale Holdings Inc. -
Giving elderly people and their caregiving families more reason to smile
Masashi Enami
President, Emimen Co., Ltd. -
Developing revolutionary drugs for diseases without effective treatment options
Takuro Wakabayashi
Chief Executive Officer, TMS Co., Ltd. -
All motivation stems from an attitude to find something interesting
Noriyuki Suzuki
President, Asterisk Inc. -
Captivating the world with manga, anime, and events
Takuro Ando
Founder & CEO, TORICO Co., Ltd. -
Keep innovating the vision of the contact center support operation
Tomohiro Ishii
President & CEO, Mobilus Corporation -
Turn customer voices into the growth engine of the company and business
Yusuke Yokoji
Representative Director, G-NEXT Inc. -
Aiming to Create a Cashless Society
Kentaro Sugiyama, President and CEO
Akira Takano, Executive Chairman
GMO Financial Gate, Inc. -
Aiming to provide platform services for store operations
Hiroshi Yamamoto
Representative Director, Smaregi, Inc. -
Desire to offer drugs that make it possible to be reborn for patients suffering from rare genetic diseases and their families as early as possible
Koji Fuji
CEO and COO, Reborna Biosciences, Inc. -
Establish new business field to substitute people’s hearing
Koji Mitsumoto
Representative Director and CEO, Hmcomm Inc. -
Aims to develop cancer drugs that you can recommend to a cancer patient in your family with confidence
Kiyoshi Eshima, Ph.D.
President, Delta-Fly Pharma -
Our mission is to create Japanese cybersecurity solutions for the global market
Yuji Ukai
President, FFRI Inc.